Related Experiment Video
Updated: Jul 17, 2026
Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt
Published on: May 7, 2015
Editorial: Intravenous Proton Pump Inhibitors for Bleeding Peptic Ulcer: What is the Most Cost-Effective Approach?
Kathryn Peterson1, David J Bjorkman2
1Department of Internal Medicine, Division of Gastroenterology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Insights
Peptic ulcers affect 10% of people. Efficient patient management, not specific proton pump inhibitor (PPI) dosing, is key to reducing costs associated with peptic ulcer bleeding.
Area of Science:
- Gastroenterology
- Internal Medicine
- Health Economics
Background:
- Peptic ulcer disease affects approximately 10% of the population.
- Upper gastrointestinal bleeding from peptic ulcers causes significant morbidity, mortality, and healthcare costs.
- Proton pump inhibitors (PPIs) are crucial for managing peptic ulcer bleeding, but their administration remains debated.
Purpose of the Study:
- To analyze the cost-effectiveness of different intravenous proton pump inhibitor (PPI) administration strategies for peptic ulcer bleeding.
- To identify the primary drivers of healthcare costs in managing bleeding peptic ulcers.
Main Methods:
- Cost analysis of patient data related to peptic ulcer bleeding.
- Comparison of treatment protocols involving varying intravenous PPI dosing and administration.
- Evaluation of patient triage and discharge efficiency.
Main Results:
- Variations in intravenous PPI administration details had a minimal impact on overall costs.
- Efficient patient triage and timely discharge were identified as major factors influencing cost reduction.
- The study highlights the economic impact of operational efficiency over specific drug administration protocols.
Conclusions:
- Optimizing patient flow and discharge processes is more critical for cost control in peptic ulcer bleeding than intricate PPI administration strategies.
- Healthcare providers should focus on streamlining patient management pathways to reduce the economic burden of peptic ulcer bleeding.
- Further research into efficient healthcare delivery models is warranted for managing gastrointestinal bleeding.
Abstract:
During their lifetime, about 10% of the population will develop a peptic ulcer. Despite major advancements in the approach to peptic ulcer bleeding over the last 10-20 years including newer endoscopic hemostatic techniques and the advent of proton pump inhibitors (PPIs), upper gastrointestinal bleeding due to peptic ulcers results in substantial morbidity, mortality, and cost. Both oral and intravenous PPIs have proven to be effective in preventing recurrent bleeding from peptic ulcers. However, the dosing and administration of PPIs have been a source of ongoing debate, specifically in relation to cost. In this issue of the Journal, Lu et al. perform cost analysis demonstrating that costs from bleeding peptic ulcers are influenced more by efficient triage and discharge of patients than the nuances of variations in administration of intravenous PPI's.
Related Concept Videos
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease